Biogen Idec builds blockbuster case for new MS drug BG-12
- 10:57 AM — Apr 24 —
- Source: Fierce Biotech
Biogen Idec is backing up its blockbuster expectations for the MS drug BG-12 with a slate of efficacy and safety data gathered in a late-stage study. Read More
Advertisement
Doug Williams



